Article Correctness Is Author's Responsibility: Sphingotec’s biomarker penKid® predicts septic acute kidney injury

(sphingotec GmbH) Sphingotec reports study data demonstrating that its proprietary renal function biomarker penKid® (Proenkephalin) predicts acute kidney injury (AKI), multi-organ failure and mortality in sepsis patients presenting to the emergency department (ED).